tion. Nonunion bone fractures and large bone defects, particularly at load-bearing sites, represent a major healthcare burden and can drastically reduce the long-term quality of life of patients. [3] The current gold standard for the repair of large or challenging bone defects is the use of autologous or allogeneic bone grafts, with at least 2.2 million bone grafting procedures being performed annually worldwide. [4] The efficacy of freshly harvested bone autografts relies primarily on the presence of living differentiated and progenitor cells, which lead to osseointegration (structural and functional connection with native bone) and osteoconduction (growth and matrix deposition of bone-related cells on the surface) after transplantation, both key processes for new bone formation. [5, 6] Depending on the availability of growth factors in bone autografts from different donors, osteoinductive properties are sometimes also present and actively induce new bone formation through biomolecular signals and recruitment of osteoprogenitor cells. [5] [6] [7] Due to these properties, bone autografts can generally achieve satisfactory healing outcomes, but this approach suffers from several critical limitations including insufficient bone volume for harvesting, donor site morbidity, and increased risk of complications due to additional surgery. [8, 9] Bone allografts can compensate for the shortcomings of autografts to some extent, but have other drawbacks such as reduced graft bioactivity, poor integration with native tissue, and limited supply. [10] Driven by the pressing clinical need to develop alternative treatment therapies that can achieve the same outcomes as bone autografts and allografts but without their associated drawbacks, the field of bone tissue engineering emerged and has seen rapid progress over the past few decades. Historical approaches to bone tissue engineering leaned heavily toward using either biological or engineering techniques to produce tissue constructs for promoting bone regeneration. Modern approaches are shifting toward more integrated strategies that are at the interface of biology and engineering, typically involving the use of a biomaterial to provide a biocompatible or even bioactive or biomimetic platform for tissue regeneration to occur. However, despite these unifying approaches, researchers are yet to develop an optimal strategy that can simultaneously address the diverse regenerative requirements of bone tissue. This review will introduce the types of current approaches
The successful regeneration of bone tissue to replace areas of bone loss in large defects or at load-bearing sites remains a significant clinical challenge. Over the past few decades, major progress is achieved in the field of bone tissue engineering to provide alternative therapies, particularly through approaches that are at the interface of biology and engineering. To satisfy the diverse regenerative requirements of bone tissue, the field moves toward highly integrated approaches incorporating the knowledge and techniques from multiple disciplines, and typically involves the use of biomaterials as an essential element for supporting or inducing bone regeneration. This review summarizes the types of approaches currently used in bone tissue engineering, beginning with those primarily based on biology or engineering, and moving into integrated approaches in the areas of biomaterial developments, biomimetic design, and scalable methods for treating large or load-bearing bone defects, while highlighting potential areas for collaboration and providing an outlook on future developments.
Introduction
Bone is a highly dynamic and vascularized tissue that plays the crucial role of providing mechanical support, mobility, and load-bearing for the body. [1] Bone tissue undergoes constant resorption and reformation, [2] and this unique remodeling capability allows small bone injuries to heal in most cases, provided that the tissue damage is below a critical size. [1, 2] However, adequate healing following significant trauma or loss of www.advancedsciencenews.com www.advhealthmat.de used in bone tissue engineering, highlighting the collaboration between different disciplines and providing an outlook on future research directions.
Current Approaches to Bone Tissue Engineering
The field of bone tissue engineering has evolved over the past decades into a highly dynamic field incorporating the knowledge and techniques from different disciplines, with the aim of developing novel and clinically viable methods of inducing bone regeneration. Currently, the range of approaches adopted in bone tissue engineering can be broadly classified as biologybased and engineering-based. This section will discuss some of the recent and interesting research in each category, and identify areas of cross-talk between categories.
Biology-Based Approaches to Bone Tissue Engineering
An extensive body of research in bone tissue engineering is based on advancing the understanding of biological processes involved in bone development and healing, leading to the ability to harness the cellular activities, biochemical processes and microenvironmental cues necessary to induce bone regeneration. Recently, tissue engineered bone constructs have been produced using a range of interesting techniques, such as subjecting relevant cell types to an environment mimicking natural bone development, and utilizing osteogenic growth factors or inflammatory mediators to prime new bone formation. Long bones in the human body naturally form through the process of endochondral ossification, whereby chondrocytes in the developing cartilaginous template undergo hypertrophy and direct cartilage remodeling into bone. In contrast, the majority of cell-based bone tissue engineering strategies to date have focused on the direct osteogenic priming of cell-seeded scaffolds in a process resembling intramembranous ossification, which often result in insufficient graft vascularization. To regenerate bone through the natural process of endochondral ossification, one approach is to produce anatomically shaped hypertrophic cartilaginous constructs using mesenchymal stem cells (MSCs). [11, 12] Porcine MSCs encapsulated in alginate hydrogels were used to form an anatomically shaped hypertrophic precursor of the distal phalanx, and attached to a layer of cartilage formed through the self-assembly of porcine chondrocytes. Following chondrogenic priming and subcutaneous implantation in nude mice, the hypertrophic phase of the tissue engineered phalanx underwent endochondral ossification, leading to the generation of vascularized bone integrated with a covering layer of articular cartilage. [12] Through a similar approach but using rat nasal chondrocytes grown on polyglycolic acid scaffolds, hypertrophic cartilaginous constructs were produced and implanted into a rat cranial defect. This resulted in angiogenesis, mineralization, and remodeling of the cartilage tissue into bone in a process analogous to endochondral ossification. [13] The discovery and isolation of bone morphogenetic proteins (BMPs) was historically one of the most impactful breakthroughs in the field of bone tissue engineering. [14, 15] Recombinant human BMP-2 and BMP-7 are currently in clinical use to augment bone reconstruction procedures. However, despite being potent growth factors for bone formation and repair due to their strong osteoinductive ability, the relation between dosage and time course of BMP administration and subsequent effects on the nature and speed of bone regeneration has not been well characterized. In this space, one study compared the micro-and nanostructure of bone formed when polycaprolactone (PCL)-tricalcium phosphate scaffolds were implanted in critical-sized segmental bone defects in sheep tibiae, with or without being loaded with BMP-2. [16] After 3 and 12 months, accelerated bone formation was observed in the scaffolds loaded with BMP-2, but the newly formed bone exhibited similar structural properties on the micro-and nanoscale compared to scaffolds without BMP-2. In another study, BMP-2 was encapsulated in collagen (for long-term delivery) or gelatin (for short-term delivery), and delivered using a PCL/poly(lacticco-glycolic acid) (PLGA) scaffold in a critical-sized rabbit segmental diaphyseal defect. [17] The best bone healing outcomes were obtained for long-term delivery of BMP-2 (up to 4 weeks), while burst release of BMP-2 induced a severe inflammatory response. Studies such as these suggest that BMPs act mainly by accelerating the rate of bone formation rather than altering the structure and morphology of the newly formed bone, and sustained delivery is associated with improved healing outcomes.
Another group of interesting studies in the area of inducing bone regeneration through biomolecular signaling utilizes inflammatory mediators such as tumor necrosis factor-α (TNF-α). In one study, human primary osteoblasts (HOBs) exposed to TNF-α for 24 h showed significant upregulation of osteogenic gene expression compared to HOBs not exposed to TNF-α or those continuously exposed to TNF-α for up to 7 d. [18] HOBs exposed to TNF-α for 24 h were also found to significantly enhance the osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells (ASCs) in a co-culture system. In a follow-up study, short-term preconditioning of ASCs with TNF-α for 3 d was found to increase proliferation, mobilization, and osteogenic differentiation of the ASCs accompanied by upregulated BMP-2 protein levels. [19] These results collectively demonstrated that inflammation plays a key role in initiating bone healing after injury, and exposure duration to inflammatory mediators such as TNF-α is a critical element in determining the subsequent effects on bone regeneration.
In these examples of biology-based bone tissue engineering approaches, the focus has been placed on understanding and utilizing the cellular and biomolecular pathways leading to bone repair and regeneration. Biomaterials have played an integral role in most of these studies by providing structural support for tissue regeneration and a platform for testing the effects of varying biological parameters. Nevertheless, the capacity to utilize biomaterials not only as a supporting matrix but as a means to actively induce osteogenesis has been largely overlooked.
Engineering-Based Approaches to Bone Tissue Engineering
Parallel to developments in biology-based approaches are engineering-based approaches to bone tissue engineering, which www.advancedsciencenews.com www.advhealthmat.de focus almost exclusively on reproducing the structural and mechanical functions of bone using synthetic materials. A significant challenge faced by researchers in this area is to produce biomaterial scaffolds that replicate the highly porous structure of cancellous bone, which is essential for vascularization and bone ingrowth, while possessing high mechanical strength to provide sufficient support when implanted in load-bearing defects. Current bone graft substitute materials in clinical use are dominated by calcium phosphate ceramics and bioactive glasses, which are mostly supplied as blocks or granules that do not resemble the characteristics of native bone. A range of engineering techniques have been applied to improve the structural and mechanical properties of currently available ceramic bone graft substitutes, such as introducing a reinforcing polymer coating to the ceramic substrate, modulating the microporosity of the ceramic, and exploring alternative fabrication routes. A simple and effective method to improve the mechanical properties of ceramic scaffolds while preserving a highly porous architecture is to deposit a polymer coating on the scaffold surface. [20, 21] The brittleness and low mechanical strength of porous ceramic scaffolds are mainly the result of imperfections in the ceramic microstructure produced during sintering, which can easily lead to crack propagation under load. Coating ceramic scaffolds with a polymer layer can fill in these microstructural defects and lead to a macroscopic improvement in strength and toughness. A range of natural and synthetic polymers have been used to coat different types of ceramic scaffolds. [20] BCP scaffolds are commonly chosen as a test substrate due to their chemical similarity to clinically used calcium phosphate-based bone graft substitutes. Some studies involving PCL-coated BCP scaffolds showed significantly increased compressive strength and energy absorbed before failure, and revealed that the main toughening mechanism in these composites was crack bridging by polymer fibrils, which was similar to the action of collagen fibrils in natural bone. [22, 23] Another interesting study deposited multiple coating layers of silk fibroin on BCP scaffolds to create a microstructural composite. [24] The mechanical behavior of the BCP scaffold could be progressively modified by increasing the number of silk coatings to produce a more elastic response under compressive loading, with up to sixfold improvement in compressive strength being achieved for five times coated scaffolds.
It is well known that the processes of in vivo bone formation and remodeling are intimately linked to vascularization. High porosity and pore sizes in a scaffold can therefore lead to direct osteogenesis by providing high oxygen tension through rapid vascularization, which favors the differentiation of MSCs into the osteoblast lineage. [25] However, the contribution of the microporosity of ceramic scaffolds to scaffold properties and the outcome of osteogenesis is less well characterized. Intuitively, a reduction in ceramic microporosity will lead to increased compressive strength, as shown in a study that fabricated glassceramic scaffolds with highly densified struts. [26] From a biological perspective, however, scaffolds with multiscale porosity may be desirable due to their microstructural imitation of cancellous bone. For example, BCP scaffolds with both macro porosity (>100 µm pores) and microporosity (1-10 µm pores) can lead to enhanced osteogenesis, possibly due to the micropores facilitating multiscale osseointegration and providing nesting sites for osteogenic cells to form osteoid and mineralized matrix. [27] The control of both macro-and microporosity may therefore be a key parameter in modulating the mechanical and biological behavior of ceramic scaffolds for bone regeneration.
The exploration of modern fabrication techniques such as additive manufacturing can facilitate the production of ceramic scaffolds with highly controlled structural and mechanical properties without necessarily altering their material composition. In this area, different types of solid free-form fabrication (SFF) techniques, including 3D printing and robocasting, have been used to generate monolithic calcium phosphate and bio active glass scaffolds with significantly higher strength-to-porosity ratio compared to traditional fabrication techniques. [27] [28] [29] The resulting scaffolds have highly regular and precisely controlled geometry, as well as greatly improved mechanical properties that can match the strength and modulus of cancellous or even cortical bone. Although some common technical difficulties such as poor material binding in 3D printing and nozzle clogging in robocasting remain to be overcome, such techniques are gaining rapid popularity as scalable forms of fabrication to produce ceramic scaffolds with improved properties for clinical use.
In the above examples of engineering-based bone tissue engineering approaches, the focus has been placed on optimizing the structural and mechanical properties of clinically available ceramic bone graft substitutes to increase their functional performance. Most studies have included in vitro or in vivo tests to ensure that improvements in the engineering properties of the scaffold are associated with the same or enhanced outcomes of bone regeneration. Nevertheless, the specific gain in osteogenic ability due to structural or mechanical improvements of the scaffold has been rarely quantified, and the mechanisms involved remain unclear.
Recent Developments toward Integrated Approaches in Bone Tissue Engineering
The field of bone tissue engineering has reached a turning point in the last 5 years, following realizations that multidisciplinary approaches are needed to produce optimal outcomes of bone regenerative therapy. Increasing emphasis is being placed on imitating the characteristics of living bone tissue, which is structurally and mechanically efficient for load-bearing and can actively respond to changing environmental stimuli. This requires bridging of the knowledge and techniques available in the areas of biology and engineering, leading to the development of biomimetic and functional bone constructs through integrated approaches. This section will discuss some of the recent advances in bone tissue engineering that are at the interface of biology and engineering.
Integrated Approaches to Bone Tissue Engineering Based on Biomaterial Developments
A relatively straightforward approach that can be easily translated into a clinically viable therapy for treating bone defects is to develop a biomaterial that satisfies all of the general www.advancedsciencenews.com www.advhealthmat.de requirements for bone regeneration. However, the multitude of requirements for promoting osteogenesis is difficult to combine into a single biomaterial, which should on the most basic level possess the following properties: biocompatibility, osteoconductivity, osteoinductivity, biodegradability, mechanical competence for load-bearing, and ability to be fabricated into scaffolds with a highly porous structure. Polymeric materials generally fall short of the ability to couple osteoinductivity and mechanical competence for load-bearing along with the other properties. For this reason, the most promising biomaterial developments for bone tissue engineering have been in the area of bioactive ceramics. Bioactive ceramics in clinical use are currently restricted to calcium phosphates and bioactive glasses, which have limited applications as scaffolds or particles for filling small or contained bone defects, and only at non load-bearing sites. [3] These materials are generally biocompatible and osteoconductive, but are usually deficient in one or more of the other necessary properties for bone regeneration. Recent research into bioactive ceramics for use as bone graft substitutes has focused on the development of calcium silicate-based ceramics. This class of materials has the advantage of being highly bioactive due to the ability to release calcium and silicate ions into the defect after implantation, which are both important mediators for bone formation. When calcium silicate ceramics are doped with various ions such as strontium, zinc, magnesium, and zirconium, which represent essential trace elements in the human body with the ability to stimulate bone formation or reduce bone resorption, a range of new ceramic formulations can be produced that exhibit enhanced mechanical and biological properties compared to currently available bone graft substitutes. [30] Two examples of calcium silicate-based bioactive ceramics that can satisfy all of the basic requirements for bone regeneration are baghdadite (containing zirconium ions) [31] and strontium-hardystonite-gahnite (Sr-HT-Gahnite, containing strontium and zinc ions). [32] Both materials can be fabricated into highly porous scaffolds while still exhibiting sufficient mechanical strength for implantation in load-bearing bone defects, and their osteogenic ability is demonstrated by the complete bridging of critical-sized segmental bone defects in a rabbit model over 12 weeks. [31, 32] In addition, baghdadite scaffolds implanted into critical-sized tibial segmental defects in a sheep model for 26 weeks achieved significant defect bridging (average 80%) for all samples, without the inclusion of cells or growth factors (Figure 1A,B) . [33] The mechanism of osteogenic induction by baghdadite was associated with its ability to upregulate BMP-2 expression, and modulate the cross-talk among cell types implicated in bone regeneration. [34] On the other hand, the properties of Sr-HT-Gahnite are due to its uniquely designed microstructure, consisting of crystalline strontiumhardystonite grains (provides bioactivity) and a wetting glass phase at the grain boundaries (prevents crack propagation),
Adv. Healthcare Mater. 2018, 7, 1701061 Figure 1 . Examples of bone tissue engineering approaches based on biomaterial developments. A) Baghdadite scaffolds achieved effective repair of a critical-sized segmental defect in the sheep tibia, with radiographic evidence of clinical union at the bone-scaffold interface, and B) histological evidence of significant and almost complete bridging of the defect. Adapted with permission. [33] Copyright 2016, IOP Publishing. C) Sr-HT-Gahnite has high bioactivity and mechanical strength due to its unique microstructure containing three different phases; D) the compressive strength of 3D printed Sr-HT-Gahnite scaffolds greatly exceeded other bioactive ceramic scaffolds at similar porosities, and were within the ranges of values reported for human cortical bone. Adapted with permission. [36] Copyright 2016, Nature Publishing Group. www.advancedsciencenews.com www.advhealthmat.de embedded within which are submicron gahnite crystals (additional crack deflectors) ( Figure 1C ). [32] Consequently, the mechanical properties of Sr-HT-Gahnite scaffolds can match cancellous bone at similar porosities (for example, compressive strength of 4.1 MPa at 85% porosity), and greatly exceed those of calcium phosphate or bioactive glass scaffolds. [32, 35] Using 3D printing, Sr-HT-Gahnite scaffolds with very high compressive strengths can be produced (90 MPa at 70% porosity), which are comparable to cortical bone and can be used in applications requiring high load bearing ( Figure 1D ). [36] Although these two examples of biomaterials resemble purely synthetic solutions to bone tissue engineering, they were deliberately designed to include biologically active elements that induce osteogenesis, and possess a well-rounded set of properties for promoting healing in large or load-bearing bone defects.
Integrated Approaches to Bone Tissue Engineering Based on Biomimetic Design
Once thought to be a collection of passively resident proteins that surround cells, the active role of the extracellular matrix (ECM) in facilitating cellular signaling and activity was only uncovered in the last two decades. In particular, the ECM of bone is critical for maintaining tissue structure and function, by providing not only mechanical support but also a niche for the growth, differentiation and interactions of cells under the influence of biochemical signals. [37] Bone ECM is a nanocomposite consisting of an organic matrix (30 wt%) primarily composed of collagen fibrils, which is mineralized with inorganic hydroxyapatite nanocrystals (70 wt%). [38] This nanostructured ECM closely surrounds the resident cells in bone and is believed to play an important role in regulating their migration, proliferation, and differentiation. [39] Some of the recent approaches in bone tissue engineering have focused on the design of biomimetic constructs to imitate the nanoscale topography and arrangement of bone ECM.
A number of studies have demonstrated the benefits of having nanoscale surface features on inducing osteogenesis. Features such as polymer nanofibers and ceramic nanoparticles can be incorporated onto the surface of biomaterial scaffolds through special processing techniques. One study fabricated nanofibrous poly(l-lactic acid) scaffolds mimicking the geometrical features of collagen fibrils using a phase separation technique. [40] When compared to solid-walled scaffolds with the same chemical composition, pore structure, and porosity, the nanofibrous scaffolds achieved significantly better osteogenesis in critical-sized rat calvarial defects. Other than a substantially higher bone volume, the nanofibrous scaffolds stained much more strongly for markers of osteoblast differentiation, collagen matrix deposition, and mineralized bone formation. Other studies have focused on introducing nanoparticles of bioactive ceramics on the surface of BCP scaffolds. BCP scaffolds coated with a surface layer of PCL containing hydroxyapatite [41] or bioactive glass [42, 43] nanoparticles (Figure 2A) were found to significantly upregulate osteogenic gene expression in primary human bone-derived cells compared to uncoated scaffolds and scaffolds coated with PCL only. The mechanism of enhanced osteogenic activity in these scaffolds was thought to be the result of the ceramic nanoparticles providing adhesion sites for the cells, as well as nanoscale features that better mimicked the arrangement of bone ECM. In a follow-up study, bioactive glass nanoparticles embedded in a PCL coating on BCP scaffolds were shown to exert a synergistic effect with 3 d of BMP-2 treatment in elevating osteogenic gene expression and alkaline phosphatase activity in ASCs. [44] In addition, this synergistic effect was found to be mediated by the activation of β1-integrin and induction of Wnt-3a autocrine signaling pathways.
A separate group of studies have investigated the effects of precisely controlled nanotopographies on the activities of bonerelated cells, by fabricating specific nanopatterns on a material substrate. These nanopatterns are generally found to have substantial effects on cell-surface interactions, which influence osteogenesis through mechanisms involving cytoskeletal changes and downstream control of cell adhesion, growth and differentiation. [45] In one study, nanogrooves with different spacing ratios (width:spacing) were fabricated on a polymer substrate using ultraviolet-assisted capillary force lithography. [46] The density of nanotopographical features was found to influence the adhesion, migration, and differentiation of human MSCs (hMSCs), but not their proliferation. Specifically, the osteogenesis or neurogenesis of hMSCs was enhanced by nanogrooves with a 1:3 spacing ratio rather than 1:1 or 1:5. In
Adv. Healthcare Mater. 2018, 7, 1701061 Figure 2 . Examples of bone tissue engineering approaches based on biomimetic design. A) Bioactive glass nanoparticles coated using polycaprolactone on the surface of biphasic calcium phosphate scaffolds mimicked the nanoscale arrangement of bone extracellular matrix, and significantly upregulated osteogenic gene expression in primary human bone-derived cells. Adapted with permission. [43] Copyright 2012, Elsevier. B) Random and aligned nanotopographies created using carbon nanotubes (left panel) influenced the shape of attached cells (right panel), resulting in different differentiation outcomes in human adipose tissue-derived mesenchymal stem cells; scale bar: 100 µm. Adapted with permission. [47] Copyright 2016, Nature Publishing Group.
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another study, substrates with aligned and random nanotopographies were fabricated by coating the surface of glass coverslips with carbon nanotubes ( Figure 2B ). [47] ASCs cultured on the aligned and random nanotopographies showed distinct differences in cell behavior. While the random topography caused cells to become more circular, the aligned topography caused cells to have an elongated shape that resulted in high expression of early stage markers of myogenic differentiation, suggesting commitment toward satellite cell muscle progenitors.
Contrary to other studies in the literature, this study showed that osteogenesis was not upregulated by an aligned topography, and suggested that the process of osteogenesis requires an overall increase in cell area by spreading in all directions rather than along one axis.
Another interesting approach to bone tissue engineering replicates the fibrillar architecture of natural ECM using nanostructured materials, which are functionalized to facilitate the sustained release of bioactive compounds such as growth factors to actively induce tissue regeneration. For example, biomolecules can be entrapped into "polymer nanoreservoirs" built on top of nanofibres using layer-by-layer technology to induce bone formation. [48] The polymer nanoreservoirs are polyelectrolyte multilayers containing biomolecules that are embedded by chemical bonding or physical adsorption. [49] Embedded biomolecules such as BMP-2 retain their biological activity, and are released through enzymatic degradation of the nanoreservoirs by cells. Polymer nanoreservoirs containing BMP-2 and transforming growth factor-β1 shaped into hollow capsules were found to induce osteogenic differentiation of mouse embryonic stem cells in vitro, as well as bone formation in a mouse subcutaneous implantation model when delivered in an alginate gel. [50] Similarly, polymer nanoreservoirs containing BMP-2 deposited onto nanofibrous collagen [51] or PCL [48] membranes demonstrated strong ability to induce osteogenesis in primary human osteoblasts and also when implanted in the skull of mice.
Recent advances in manufacturing technologies have provided powerful tools for investigating the nanoscale interactions of cells with materials. Although many studies have provided evidence that nanotopography can profoundly influence cell behavior, the specific mechanisms involved, and precise effects on the outcomes of osteogenesis remain largely unexplored, which represent an exciting area of development in bone tissue engineering.
Integrated Approaches to Bone Tissue Engineering Based on Scalable Methods for Treating Large or Load-Bearing Bone Defects
A number of highly integrated bone tissue engineering approaches have recently emerged in the literature, which aim to produce a new generation of therapeutic constructs for treating large or load-bearing bone defects using scalable methods. These approaches utilize SFF-based manufacturing techniques to reliably and efficiently produce bioactive ceramic scaffolds, which have precisely controlled geometry and high compressive strengths to facilitate the regeneration of vascularized and mechanically functional bone. Confirmation of their bioactivity and osteogenic capacity in preclinical animal models is an essential step in the translation of these scaffolds for clinical use in bone regenerative therapy.
Through a modified 3D printing process, implants termed "hyperelastic bone" could be produced rapidly from room temperature extruded liquid inks ( Figure 3A) . [52] Composed of 90 wt% hydroxyapatite (HA) and 10 wt% PCL or PLGA, these implants exhibited elastic mechanical properties (32-67% strain to failure) and supported compressive loads of 650N at
Adv. Healthcare Mater. 2018, 7, 1701061 Figure 3 . Examples of bone tissue engineering approaches based on scalable methods for treating large or load-bearing bone defects. A) "Hyperelastic bone" implants composed of 90 wt% hydroxyapatite and 10 wt% poly(lactic-co-glycolic acid) exhibited elastic mechanical behavior under compression, as well as osteoinductive properties in a rat spinal fusion model. Adapted with permission. [52] Copyright 2016, AAAS. B) Strontium-doped calcium phosphate cement (CPC) scaffolds could release strontium ions after implantation, and significantly stimulated bone formation within cancellous bone defects in the hind limbs of sheep after 6 months. Adapted with permission. [53] Copyright 2017, John Wiley and Sons. C) Silicate bioceramic scaffolds with hollow struts promoted angiogenesis and bone regeneration within a rabbit radial segmental defect, due to a synergistic effect between bioactive ions released from the scaffolds and the hollow struts enhancing blood vessel ingrowth. Adapted with permission. [54] Copyright 2017, Elsevier.
www.advancedsciencenews.com www.advhealthmat.de 50% porosity. In a rat spinal fusion model, HA/PLGA implants showed some osteoinductive ability as indicated by 46% fusion rate after 4 weeks without added cells or growth factors. The osteoinductive properties of the implant were enhanced by BMP-2 loading, which increased the fusion rate to 83%. The rapid production time of these implants is favorable for translation, but their suitability for use at load-bearing sites remains to be confirmed pending the evaluation of specific mechanical properties (such as compressive strength), as well as bio mechanical performance in an orthotopic large animal model. Also using 3D printing, strontium (Sr)-doped calcium phosphate cement (CPC) scaffolds and nondoped CPC scaffolds were produced ( Figure 3B ), which were implanted into unloaded or load-bearing cancellous bone defects in the hind limbs of sheep. [53] Although little effects were observed on early bone formation, Sr-doped CPC scaffolds and mechanical loading were found to separately and significantly stimulate bone formation after 6 months. The mechanism of increased bone formation in Sr-doped CPC scaffolds was related to the continuous release of strontium into the defect site. Another interesting study used a coaxial 3D printing technique to produce hollow-pipe-packed silicate bioceramic scaffolds, which had hollow struts with external diameter of 1 mm and internal diameter of 500 µm ( Figure 3C ). [54] Ionic dissolution products from the ceramic scaffolds were found to induce both osteogenesis and angiogenesis in vitro, while the hollow pipe structure of the scaffold struts enhanced the ingrowth of blood vessels and the delivery of stem cells and growth factors. When implanted in a rabbit radial segmental defect, the scaffolds promoted early angiogenesis and later bone regeneration and remodeling within the defect. The ionic products from the scaffolds and their hollow pipe structure were thought to have a synergistic effect on enhancing vascularized bone regeneration. The above studies are examples that point to a paradigm shift in approaches taken to develop modern therapeutic strategies in bone tissue engineering. Synthetic biomaterial scaffolds are produced using SFF-based techniques to increase repeatability and efficiency, while engineering design allows an optimal balance to be achieved between scaffold structure and mechanical properties. In addition, the scaffolds are functionalized with the ability for bioactive ion release or cell and biomolecule delivery, which facilitate the utilization of natural pathways for tissue regeneration. These approaches have the potential to collectively address the structural, mechanical, and biological cues required for the regeneration of vascularized bone tissue.
Conclusions and Future Outlook
Approaches integrating the knowledge and techniques from biology and engineering are essential for future advances in bone tissue engineering to develop effective and clinically viable therapies. Although a large number of studies have already begun to explore such integrated approaches, some examples of which are discussed in this review, a considerable gap still exists between the biology-based and engineering-based aspects of most approaches. For instance, approaches focusing on the induction of bone-related cell types toward osteogenesis by modulating the cellular microenvironment generally only involve biomaterials as a support structure or delivery vehicle. On the other hand, biomaterial implants developed for bone regeneration are generally designed to optimize their engineering properties, while their biological efficacy is often considered at a much later time.
Future research in bone tissue engineering can derive significant benefits from a deeper understanding of native tissue characteristics, developmental biology, and the natural processes of tissue repair and regeneration. Biomaterial scaffolds can be integrated with molecules that target stem cell behavior, such as inflammatory cytokines, ECM molecules and adhesive ligands, to recapacitate the earlier stages of tissue repair and remodeling. To enable the regeneration of vascularized bone, scaffolds should be designed to incorporate materials or growth factors that promote angiogenesis, and provide the necessary porosity for vascular ingrowth. Insights into the nature and mechanisms of cell responses to microenvironmental cues can be used to guide the design of a range of scaffold features, such as the inclusion of bioactive ions or nanoscale surface topographies for directing cellular adhesion, spreading, proliferation, and differentiation, and the modification of scaffold microstructure or stiffness to change mechanical properties and cell interactions. The development of these integrated strategies requires the expansion of bone tissue engineering into new fields of research beyond the traditional approaches in biology and engineering, necessitating contributions from specialized areas such as nanotechnology, mechanobiology, manufacturing technologies, biosensors, and medical diagnostics. Multidisciplinary methods in bone tissue engineering are the key to tackling the difficulties currently encountered in the clinical treatment of challenging bone defects.
